Skip to content

Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?

Effect of Acutely Lowering Intraocular Pressure on Multifocal Visual Evoked Potential Testing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00799994
Enrollment
23
Registered
2008-12-01
Start date
2004-10-31
Completion date
2007-01-31
Last updated
2016-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

glaucoma, intraocular pressure, multifocal visually evoked potentials

Brief summary

A study to determine whether a patient's range of vision test results improve after their eye pressure is lowered by 30% or more by testing on a new machine called the Accumap and how to learn how much the Accumap's results change from one test to another within the same person. The investigators believe that Multifocal VEP readings (Accumap)(and therefore visual function and ganglion cell function) improve after acutely lowering intraocular pressure.

Detailed description

Accumap testing will be performed before and two to three hours after treatment is initiated to lower IOP. In eye that have bilateral treatment, one eye will be assigned randomly to the study. The mean multifocal objective perimetry amplitude will be compared before and after IOP reduction. Also, the mean amplitudes of five circumferential zones will be compared before and after IOP lowering. Visual field testing and HRT testing will be performed before and after treatment as well if possible. Paired t-tests will be performed no pre-and post-treatment mean MOP amplitude values and circumferential zones to determine statistical significance. A second group of patients whose pressures will not be lowered will also be tested with Accumap at baseline and two hours afterwards, in order to examine reproducibility of mean MOP amplitude and mean circumferential amplitude. HVF and HRT testing will also be obtained on thes patients when possible.

Interventions

None listed

Sponsors

Pfizer
CollaboratorINDUSTRY
Wills Eye
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Consecutive patients seen that have their intraocular pressures lowered by at least 30% over the course of two hours.

Exclusion criteria

* Recent (within 6 weeks) intraocular surgery * Visual acuity worse than 20/40 * Pathology unrelated to glaucoma (retinal disease, stroke, brain tumor, etc) associated with visual field defect * Prior corneal transplant, corneal edema, or corneal diseases such as keratoconus or dense scarring

Design outcomes

Primary

MeasureTime frame
lowering of intraocular pressure will cause an acute improvement in MfVEP (multifocal visually evoked potential) amplitude readings1 day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026